Two Peaks in MIS-C Followed COVID-19 Peaks in the US
Lowest proportion of severe manifestations seen in patients aged 0 to 4 years, but 44.3 percent admitted for intensive care
Ophthalmic Disorders
Aflibercept Cuts Vision-Threatening Complications of Diabetic Retinopathy
But no improvement in visual acuity seen with aflibercept versus sham for eyes with nonproliferative diabetic retinopathy
More Tepezza Will Be Available Starting in April
Tepezza, a fully human monoclonal antibody, is approved for the treatment of thyroid eye disease.
Generic Version of Foscavir Now Available
Foscarnet sodium injection is indicated to treat cytomegalovirus retinitis in patients with AIDS and acyclovir-resistant mucocutaneous HSV in immunocompromised patients.
Generic Version of Azopt Now Available
Brinzolamide ophthalmic suspension 1% is indicated for elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Varenicline Nasal Spray Under Review for Dry Eye Disease
The investigational nasal spray contains varenicline, a highly selective nicotinic acetylcholine agonist.
New Lubricant Eye Drops Help With Eye Dryness Related to Screen Use
Refresh Digital is designed to protect tears from evaporating due to incomplete blinking during digital device use.
Pataday Once Daily Relief Extra Strength Available Over-the-Counter
Pataday Once Daily Relief Extra Strength is indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander.
Study Examines Patient Perceptions of Marijuana as Glaucoma Treatment
Research shows patients with glaucoma are likely to encounter conflicting opinions on marijuana’s role in glaucoma therapy, especially from dispensaries.
Anti-VEGF Injections May Reduce Glaucoma Burden for Some
Study shows reductions in intraocular pressures and antiglaucoma medication use.
